nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.024	0.463	CbGbCtD
Lurasidone—CYP3A4—Progesterone—uterine cancer	0.0159	0.307	CbGbCtD
Lurasidone—HTR7—artery—uterine cancer	0.00938	0.0997	CbGeAlD
Lurasidone—CYP3A4—Etoposide—uterine cancer	0.00712	0.137	CbGbCtD
Lurasidone—HTR2A—artery—uterine cancer	0.00585	0.0622	CbGeAlD
Lurasidone—CYP3A4—Doxorubicin—uterine cancer	0.00486	0.0936	CbGbCtD
Lurasidone—ADRA2C—myometrium—uterine cancer	0.00416	0.0443	CbGeAlD
Lurasidone—HTR7—epithelium—uterine cancer	0.00356	0.0378	CbGeAlD
Lurasidone—HTR1A—renal system—uterine cancer	0.00345	0.0367	CbGeAlD
Lurasidone—HTR7—smooth muscle tissue—uterine cancer	0.00343	0.0364	CbGeAlD
Lurasidone—ADRA2A—myometrium—uterine cancer	0.00332	0.0353	CbGeAlD
Lurasidone—HTR7—renal system—uterine cancer	0.0033	0.0351	CbGeAlD
Lurasidone—ADRA2C—uterine cervix—uterine cancer	0.00324	0.0344	CbGeAlD
Lurasidone—ADRA2C—decidua—uterine cancer	0.00309	0.0328	CbGeAlD
Lurasidone—ADRA2C—renal system—uterine cancer	0.00303	0.0322	CbGeAlD
Lurasidone—ADRA2C—endometrium—uterine cancer	0.00293	0.0311	CbGeAlD
Lurasidone—ADRA2C—mammalian vulva—uterine cancer	0.00284	0.0301	CbGeAlD
Lurasidone—ADRA2C—uterus—uterine cancer	0.0027	0.0287	CbGeAlD
Lurasidone—HTR7—female reproductive system—uterine cancer	0.00264	0.0281	CbGeAlD
Lurasidone—ADRA2A—uterine cervix—uterine cancer	0.00259	0.0275	CbGeAlD
Lurasidone—ADRA2A—decidua—uterine cancer	0.00246	0.0262	CbGeAlD
Lurasidone—ADRA2A—endometrium—uterine cancer	0.00234	0.0249	CbGeAlD
Lurasidone—ADRA2A—mammalian vulva—uterine cancer	0.00226	0.024	CbGeAlD
Lurasidone—HTR2A—epithelium—uterine cancer	0.00222	0.0236	CbGeAlD
Lurasidone—ADRA2C—female gonad—uterine cancer	0.00221	0.0235	CbGeAlD
Lurasidone—ADRA2C—vagina—uterine cancer	0.0022	0.0233	CbGeAlD
Lurasidone—ADRA2A—uterus—uterine cancer	0.00216	0.0229	CbGeAlD
Lurasidone—HTR2A—smooth muscle tissue—uterine cancer	0.00214	0.0227	CbGeAlD
Lurasidone—HTR2A—renal system—uterine cancer	0.00206	0.0219	CbGeAlD
Lurasidone—ADRA2A—female reproductive system—uterine cancer	0.00194	0.0206	CbGeAlD
Lurasidone—CYP3A4—renal system—uterine cancer	0.0019	0.0202	CbGeAlD
Lurasidone—ADRA2A—female gonad—uterine cancer	0.00176	0.0187	CbGeAlD
Lurasidone—ADRA2A—vagina—uterine cancer	0.00175	0.0186	CbGeAlD
Lurasidone—Pulmonary embolism—Epirubicin—uterine cancer	0.00174	0.00203	CcSEcCtD
Lurasidone—Infestation NOS—Etoposide—uterine cancer	0.00173	0.00203	CcSEcCtD
Lurasidone—Infestation—Etoposide—uterine cancer	0.00173	0.00203	CcSEcCtD
Lurasidone—Anaemia—Dactinomycin—uterine cancer	0.00173	0.00203	CcSEcCtD
Lurasidone—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00202	CcSEcCtD
Lurasidone—Abnormal dreams—Epirubicin—uterine cancer	0.00172	0.00201	CcSEcCtD
Lurasidone—Dyskinesia—Doxorubicin—uterine cancer	0.00171	0.002	CcSEcCtD
Lurasidone—Abdominal pain—Progesterone—uterine cancer	0.00171	0.002	CcSEcCtD
Lurasidone—Renal failure—Etoposide—uterine cancer	0.0017	0.00199	CcSEcCtD
Lurasidone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00199	CcSEcCtD
Lurasidone—Dysarthria—Doxorubicin—uterine cancer	0.0017	0.00199	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00198	CcSEcCtD
Lurasidone—Creatinine increased—Doxorubicin—uterine cancer	0.00169	0.00198	CcSEcCtD
Lurasidone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00198	CcSEcCtD
Lurasidone—Malaise—Dactinomycin—uterine cancer	0.00169	0.00198	CcSEcCtD
Lurasidone—Salivary hypersecretion—Epirubicin—uterine cancer	0.00169	0.00198	CcSEcCtD
Lurasidone—Leukopenia—Dactinomycin—uterine cancer	0.00168	0.00196	CcSEcCtD
Lurasidone—Atrioventricular block—Doxorubicin—uterine cancer	0.00166	0.00194	CcSEcCtD
Lurasidone—HTR2A—female reproductive system—uterine cancer	0.00165	0.0175	CbGeAlD
Lurasidone—Gait disturbance—Doxorubicin—uterine cancer	0.00165	0.00193	CcSEcCtD
Lurasidone—Hepatobiliary disease—Etoposide—uterine cancer	0.00164	0.00192	CcSEcCtD
Lurasidone—Neck pain—Doxorubicin—uterine cancer	0.00163	0.0019	CcSEcCtD
Lurasidone—Agranulocytosis—Etoposide—uterine cancer	0.00162	0.00189	CcSEcCtD
Lurasidone—Pulmonary embolism—Doxorubicin—uterine cancer	0.00161	0.00188	CcSEcCtD
Lurasidone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00187	CcSEcCtD
Lurasidone—Myalgia—Dactinomycin—uterine cancer	0.00159	0.00187	CcSEcCtD
Lurasidone—Abnormal dreams—Doxorubicin—uterine cancer	0.00159	0.00186	CcSEcCtD
Lurasidone—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00156	0.00183	CcSEcCtD
Lurasidone—Asthenia—Progesterone—uterine cancer	0.00155	0.00182	CcSEcCtD
Lurasidone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00181	CcSEcCtD
Lurasidone—Urinary tract disorder—Etoposide—uterine cancer	0.00154	0.0018	CcSEcCtD
Lurasidone—Pruritus—Progesterone—uterine cancer	0.00153	0.00179	CcSEcCtD
Lurasidone—Urethral disorder—Etoposide—uterine cancer	0.00153	0.00179	CcSEcCtD
Lurasidone—CYP3A4—female reproductive system—uterine cancer	0.00153	0.0162	CbGeAlD
Lurasidone—Infection—Dactinomycin—uterine cancer	0.00152	0.00178	CcSEcCtD
Lurasidone—HTR2A—vagina—uterine cancer	0.00149	0.0158	CbGeAlD
Lurasidone—Diarrhoea—Progesterone—uterine cancer	0.00148	0.00173	CcSEcCtD
Lurasidone—Eye disorder—Etoposide—uterine cancer	0.00145	0.0017	CcSEcCtD
Lurasidone—Diabetes mellitus—Epirubicin—uterine cancer	0.00145	0.0017	CcSEcCtD
Lurasidone—Cardiac disorder—Etoposide—uterine cancer	0.00144	0.00169	CcSEcCtD
Lurasidone—Dizziness—Progesterone—uterine cancer	0.00143	0.00167	CcSEcCtD
Lurasidone—ADRA2C—lymph node—uterine cancer	0.00142	0.0151	CbGeAlD
Lurasidone—Angiopathy—Etoposide—uterine cancer	0.00141	0.00165	CcSEcCtD
Lurasidone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00165	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00139	0.00163	CcSEcCtD
Lurasidone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00162	CcSEcCtD
Lurasidone—Vomiting—Progesterone—uterine cancer	0.00137	0.00161	CcSEcCtD
Lurasidone—Rash—Progesterone—uterine cancer	0.00136	0.0016	CcSEcCtD
Lurasidone—Dermatitis—Progesterone—uterine cancer	0.00136	0.00159	CcSEcCtD
Lurasidone—Hot flush—Epirubicin—uterine cancer	0.00135	0.00158	CcSEcCtD
Lurasidone—Increased appetite—Epirubicin—uterine cancer	0.00134	0.00157	CcSEcCtD
Lurasidone—Diabetes mellitus—Doxorubicin—uterine cancer	0.00134	0.00157	CcSEcCtD
Lurasidone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00157	CcSEcCtD
Lurasidone—Menopausal symptoms—Epirubicin—uterine cancer	0.00134	0.00156	CcSEcCtD
Lurasidone—Decreased appetite—Dactinomycin—uterine cancer	0.00133	0.00155	CcSEcCtD
Lurasidone—Fatigue—Dactinomycin—uterine cancer	0.00132	0.00154	CcSEcCtD
Lurasidone—Back pain—Etoposide—uterine cancer	0.00131	0.00153	CcSEcCtD
Lurasidone—Muscle spasms—Etoposide—uterine cancer	0.0013	0.00152	CcSEcCtD
Lurasidone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00152	CcSEcCtD
Lurasidone—Lethargy—Epirubicin—uterine cancer	0.00129	0.00151	CcSEcCtD
Lurasidone—Cerebrovascular accident—Epirubicin—uterine cancer	0.00129	0.00151	CcSEcCtD
Lurasidone—Nausea—Progesterone—uterine cancer	0.00128	0.0015	CcSEcCtD
Lurasidone—Osteoarthritis—Epirubicin—uterine cancer	0.00126	0.00148	CcSEcCtD
Lurasidone—Anaemia—Etoposide—uterine cancer	0.00125	0.00147	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00125	0.00146	CcSEcCtD
Lurasidone—Hot flush—Doxorubicin—uterine cancer	0.00125	0.00146	CcSEcCtD
Lurasidone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00146	CcSEcCtD
Lurasidone—Increased appetite—Doxorubicin—uterine cancer	0.00124	0.00145	CcSEcCtD
Lurasidone—Menopausal symptoms—Doxorubicin—uterine cancer	0.00124	0.00145	CcSEcCtD
Lurasidone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00145	CcSEcCtD
Lurasidone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00144	CcSEcCtD
Lurasidone—Malaise—Etoposide—uterine cancer	0.00122	0.00143	CcSEcCtD
Lurasidone—Vertigo—Etoposide—uterine cancer	0.00122	0.00142	CcSEcCtD
Lurasidone—Leukopenia—Etoposide—uterine cancer	0.00121	0.00142	CcSEcCtD
Lurasidone—Abdominal pain—Dactinomycin—uterine cancer	0.00121	0.00141	CcSEcCtD
Lurasidone—Loss of consciousness—Etoposide—uterine cancer	0.00119	0.00139	CcSEcCtD
Lurasidone—Lethargy—Doxorubicin—uterine cancer	0.00119	0.00139	CcSEcCtD
Lurasidone—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00119	0.00139	CcSEcCtD
Lurasidone—Blood creatinine increased—Epirubicin—uterine cancer	0.00118	0.00138	CcSEcCtD
Lurasidone—Convulsion—Etoposide—uterine cancer	0.00117	0.00137	CcSEcCtD
Lurasidone—Hypertension—Etoposide—uterine cancer	0.00117	0.00137	CcSEcCtD
Lurasidone—Osteoarthritis—Doxorubicin—uterine cancer	0.00117	0.00137	CcSEcCtD
Lurasidone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00136	CcSEcCtD
Lurasidone—Orthostatic hypotension—Epirubicin—uterine cancer	0.00115	0.00135	CcSEcCtD
Lurasidone—Abdominal pain upper—Epirubicin—uterine cancer	0.00115	0.00135	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00115	0.00134	CcSEcCtD
Lurasidone—Breast disorder—Epirubicin—uterine cancer	0.00114	0.00133	CcSEcCtD
Lurasidone—ADRA2A—lymph node—uterine cancer	0.00113	0.012	CbGeAlD
Lurasidone—Nasopharyngitis—Epirubicin—uterine cancer	0.00113	0.00132	CcSEcCtD
Lurasidone—Gastritis—Epirubicin—uterine cancer	0.00112	0.00131	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00111	0.0013	CcSEcCtD
Lurasidone—Infection—Etoposide—uterine cancer	0.0011	0.00129	CcSEcCtD
Lurasidone—Asthenia—Dactinomycin—uterine cancer	0.0011	0.00128	CcSEcCtD
Lurasidone—Blood creatinine increased—Doxorubicin—uterine cancer	0.00109	0.00128	CcSEcCtD
Lurasidone—Influenza—Epirubicin—uterine cancer	0.00109	0.00128	CcSEcCtD
Lurasidone—Dysphagia—Epirubicin—uterine cancer	0.00109	0.00128	CcSEcCtD
Lurasidone—Tachycardia—Etoposide—uterine cancer	0.00108	0.00126	CcSEcCtD
Lurasidone—Eosinophilia—Epirubicin—uterine cancer	0.00108	0.00126	CcSEcCtD
Lurasidone—Skin disorder—Etoposide—uterine cancer	0.00107	0.00126	CcSEcCtD
Lurasidone—Hyperhidrosis—Etoposide—uterine cancer	0.00107	0.00125	CcSEcCtD
Lurasidone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00107	0.00125	CcSEcCtD
Lurasidone—Abdominal pain upper—Doxorubicin—uterine cancer	0.00107	0.00125	CcSEcCtD
Lurasidone—Angina pectoris—Epirubicin—uterine cancer	0.00106	0.00124	CcSEcCtD
Lurasidone—Breast disorder—Doxorubicin—uterine cancer	0.00105	0.00123	CcSEcCtD
Lurasidone—Diarrhoea—Dactinomycin—uterine cancer	0.00104	0.00122	CcSEcCtD
Lurasidone—Nasopharyngitis—Doxorubicin—uterine cancer	0.00104	0.00122	CcSEcCtD
Lurasidone—Hypotension—Etoposide—uterine cancer	0.00103	0.00121	CcSEcCtD
Lurasidone—Gastritis—Doxorubicin—uterine cancer	0.00103	0.00121	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00103	0.0012	CcSEcCtD
Lurasidone—Dysuria—Epirubicin—uterine cancer	0.00102	0.00119	CcSEcCtD
Lurasidone—Neutropenia—Epirubicin—uterine cancer	0.00102	0.00119	CcSEcCtD
Lurasidone—Dysphagia—Doxorubicin—uterine cancer	0.00101	0.00118	CcSEcCtD
Lurasidone—Influenza—Doxorubicin—uterine cancer	0.00101	0.00118	CcSEcCtD
Lurasidone—Eosinophilia—Doxorubicin—uterine cancer	0.000998	0.00117	CcSEcCtD
Lurasidone—Weight increased—Epirubicin—uterine cancer	0.000992	0.00116	CcSEcCtD
Lurasidone—Dyspnoea—Etoposide—uterine cancer	0.000985	0.00115	CcSEcCtD
Lurasidone—Hyperglycaemia—Epirubicin—uterine cancer	0.000983	0.00115	CcSEcCtD
Lurasidone—Somnolence—Etoposide—uterine cancer	0.000983	0.00115	CcSEcCtD
Lurasidone—Angina pectoris—Doxorubicin—uterine cancer	0.000982	0.00115	CcSEcCtD
Lurasidone—Infestation NOS—Epirubicin—uterine cancer	0.000971	0.00114	CcSEcCtD
Lurasidone—Infestation—Epirubicin—uterine cancer	0.000971	0.00114	CcSEcCtD
Lurasidone—Vomiting—Dactinomycin—uterine cancer	0.000971	0.00114	CcSEcCtD
Lurasidone—Rash—Dactinomycin—uterine cancer	0.000963	0.00113	CcSEcCtD
Lurasidone—Decreased appetite—Etoposide—uterine cancer	0.000961	0.00113	CcSEcCtD
Lurasidone—Renal failure—Epirubicin—uterine cancer	0.000955	0.00112	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000954	0.00112	CcSEcCtD
Lurasidone—Fatigue—Etoposide—uterine cancer	0.000953	0.00112	CcSEcCtD
Lurasidone—Urinary tract infection—Epirubicin—uterine cancer	0.000944	0.00111	CcSEcCtD
Lurasidone—Dysuria—Doxorubicin—uterine cancer	0.000943	0.0011	CcSEcCtD
Lurasidone—Neutropenia—Doxorubicin—uterine cancer	0.000943	0.0011	CcSEcCtD
Lurasidone—Hepatobiliary disease—Epirubicin—uterine cancer	0.000919	0.00108	CcSEcCtD
Lurasidone—Weight increased—Doxorubicin—uterine cancer	0.000917	0.00107	CcSEcCtD
Lurasidone—Hyperglycaemia—Doxorubicin—uterine cancer	0.000909	0.00106	CcSEcCtD
Lurasidone—Nausea—Dactinomycin—uterine cancer	0.000907	0.00106	CcSEcCtD
Lurasidone—Agranulocytosis—Epirubicin—uterine cancer	0.000907	0.00106	CcSEcCtD
Lurasidone—Gastrointestinal pain—Etoposide—uterine cancer	0.000904	0.00106	CcSEcCtD
Lurasidone—Infestation NOS—Doxorubicin—uterine cancer	0.000899	0.00105	CcSEcCtD
Lurasidone—Infestation—Doxorubicin—uterine cancer	0.000899	0.00105	CcSEcCtD
Lurasidone—Bradycardia—Epirubicin—uterine cancer	0.000888	0.00104	CcSEcCtD
Lurasidone—Renal failure—Doxorubicin—uterine cancer	0.000884	0.00103	CcSEcCtD
Lurasidone—Abdominal pain—Etoposide—uterine cancer	0.000874	0.00102	CcSEcCtD
Lurasidone—Urinary tract infection—Doxorubicin—uterine cancer	0.000874	0.00102	CcSEcCtD
Lurasidone—Urinary tract disorder—Epirubicin—uterine cancer	0.000861	0.00101	CcSEcCtD
Lurasidone—Connective tissue disorder—Epirubicin—uterine cancer	0.000857	0.001	CcSEcCtD
Lurasidone—Urethral disorder—Epirubicin—uterine cancer	0.000855	0.001	CcSEcCtD
Lurasidone—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00085	0.000996	CcSEcCtD
Lurasidone—Agranulocytosis—Doxorubicin—uterine cancer	0.000839	0.000982	CcSEcCtD
Lurasidone—Bradycardia—Doxorubicin—uterine cancer	0.000821	0.000962	CcSEcCtD
Lurasidone—Eye disorder—Epirubicin—uterine cancer	0.000815	0.000954	CcSEcCtD
Lurasidone—Cardiac disorder—Epirubicin—uterine cancer	0.000809	0.000948	CcSEcCtD
Lurasidone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000797	0.000933	CcSEcCtD
Lurasidone—Asthenia—Etoposide—uterine cancer	0.000793	0.000929	CcSEcCtD
Lurasidone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000793	0.000929	CcSEcCtD
Lurasidone—Angiopathy—Epirubicin—uterine cancer	0.000791	0.000927	CcSEcCtD
Lurasidone—Urethral disorder—Doxorubicin—uterine cancer	0.000791	0.000926	CcSEcCtD
Lurasidone—Pruritus—Etoposide—uterine cancer	0.000782	0.000916	CcSEcCtD
Lurasidone—Arrhythmia—Epirubicin—uterine cancer	0.000779	0.000912	CcSEcCtD
Lurasidone—Mental disorder—Epirubicin—uterine cancer	0.000764	0.000895	CcSEcCtD
Lurasidone—Malnutrition—Epirubicin—uterine cancer	0.000759	0.000889	CcSEcCtD
Lurasidone—Diarrhoea—Etoposide—uterine cancer	0.000756	0.000886	CcSEcCtD
Lurasidone—Eye disorder—Doxorubicin—uterine cancer	0.000754	0.000883	CcSEcCtD
Lurasidone—Cardiac disorder—Doxorubicin—uterine cancer	0.000749	0.000877	CcSEcCtD
Lurasidone—Flatulence—Epirubicin—uterine cancer	0.000748	0.000876	CcSEcCtD
Lurasidone—Back pain—Epirubicin—uterine cancer	0.000734	0.00086	CcSEcCtD
Lurasidone—Angiopathy—Doxorubicin—uterine cancer	0.000732	0.000857	CcSEcCtD
Lurasidone—Dizziness—Etoposide—uterine cancer	0.000731	0.000856	CcSEcCtD
Lurasidone—Muscle spasms—Epirubicin—uterine cancer	0.00073	0.000855	CcSEcCtD
Lurasidone—Arrhythmia—Doxorubicin—uterine cancer	0.000721	0.000844	CcSEcCtD
Lurasidone—Vision blurred—Epirubicin—uterine cancer	0.000715	0.000838	CcSEcCtD
Lurasidone—Mental disorder—Doxorubicin—uterine cancer	0.000707	0.000828	CcSEcCtD
Lurasidone—Vomiting—Etoposide—uterine cancer	0.000703	0.000823	CcSEcCtD
Lurasidone—Malnutrition—Doxorubicin—uterine cancer	0.000702	0.000823	CcSEcCtD
Lurasidone—Anaemia—Epirubicin—uterine cancer	0.000702	0.000822	CcSEcCtD
Lurasidone—Agitation—Epirubicin—uterine cancer	0.000698	0.000817	CcSEcCtD
Lurasidone—Rash—Etoposide—uterine cancer	0.000697	0.000816	CcSEcCtD
Lurasidone—Dermatitis—Etoposide—uterine cancer	0.000696	0.000815	CcSEcCtD
Lurasidone—Flatulence—Doxorubicin—uterine cancer	0.000692	0.000811	CcSEcCtD
Lurasidone—Malaise—Epirubicin—uterine cancer	0.000685	0.000802	CcSEcCtD
Lurasidone—Vertigo—Epirubicin—uterine cancer	0.000682	0.000799	CcSEcCtD
Lurasidone—Syncope—Epirubicin—uterine cancer	0.000681	0.000797	CcSEcCtD
Lurasidone—Leukopenia—Epirubicin—uterine cancer	0.00068	0.000796	CcSEcCtD
Lurasidone—Back pain—Doxorubicin—uterine cancer	0.000679	0.000796	CcSEcCtD
Lurasidone—Muscle spasms—Doxorubicin—uterine cancer	0.000675	0.000791	CcSEcCtD
Lurasidone—Loss of consciousness—Epirubicin—uterine cancer	0.000667	0.000781	CcSEcCtD
Lurasidone—Vision blurred—Doxorubicin—uterine cancer	0.000662	0.000775	CcSEcCtD
Lurasidone—Convulsion—Epirubicin—uterine cancer	0.000658	0.00077	CcSEcCtD
Lurasidone—Nausea—Etoposide—uterine cancer	0.000657	0.000769	CcSEcCtD
Lurasidone—Hypertension—Epirubicin—uterine cancer	0.000655	0.000768	CcSEcCtD
Lurasidone—Anaemia—Doxorubicin—uterine cancer	0.000649	0.00076	CcSEcCtD
Lurasidone—Myalgia—Epirubicin—uterine cancer	0.000646	0.000757	CcSEcCtD
Lurasidone—Agitation—Doxorubicin—uterine cancer	0.000646	0.000756	CcSEcCtD
Lurasidone—Anxiety—Epirubicin—uterine cancer	0.000644	0.000754	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000642	0.000752	CcSEcCtD
Lurasidone—Malaise—Doxorubicin—uterine cancer	0.000633	0.000742	CcSEcCtD
Lurasidone—Dry mouth—Epirubicin—uterine cancer	0.000632	0.00074	CcSEcCtD
Lurasidone—Vertigo—Doxorubicin—uterine cancer	0.000631	0.000739	CcSEcCtD
Lurasidone—Syncope—Doxorubicin—uterine cancer	0.00063	0.000738	CcSEcCtD
Lurasidone—Leukopenia—Doxorubicin—uterine cancer	0.000629	0.000736	CcSEcCtD
Lurasidone—Loss of consciousness—Doxorubicin—uterine cancer	0.000617	0.000723	CcSEcCtD
Lurasidone—Infection—Epirubicin—uterine cancer	0.000616	0.000721	CcSEcCtD
Lurasidone—Shock—Epirubicin—uterine cancer	0.00061	0.000714	CcSEcCtD
Lurasidone—Convulsion—Doxorubicin—uterine cancer	0.000609	0.000713	CcSEcCtD
Lurasidone—Nervous system disorder—Epirubicin—uterine cancer	0.000608	0.000712	CcSEcCtD
Lurasidone—Hypertension—Doxorubicin—uterine cancer	0.000606	0.00071	CcSEcCtD
Lurasidone—Tachycardia—Epirubicin—uterine cancer	0.000605	0.000708	CcSEcCtD
Lurasidone—Skin disorder—Epirubicin—uterine cancer	0.000602	0.000705	CcSEcCtD
Lurasidone—Hyperhidrosis—Epirubicin—uterine cancer	0.000599	0.000701	CcSEcCtD
Lurasidone—Myalgia—Doxorubicin—uterine cancer	0.000598	0.0007	CcSEcCtD
Lurasidone—Anxiety—Doxorubicin—uterine cancer	0.000596	0.000698	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000594	0.000695	CcSEcCtD
Lurasidone—Dry mouth—Doxorubicin—uterine cancer	0.000585	0.000685	CcSEcCtD
Lurasidone—Hypotension—Epirubicin—uterine cancer	0.000579	0.000678	CcSEcCtD
Lurasidone—Infection—Doxorubicin—uterine cancer	0.00057	0.000667	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000565	0.000661	CcSEcCtD
Lurasidone—Shock—Doxorubicin—uterine cancer	0.000564	0.00066	CcSEcCtD
Lurasidone—Nervous system disorder—Doxorubicin—uterine cancer	0.000562	0.000658	CcSEcCtD
Lurasidone—Insomnia—Epirubicin—uterine cancer	0.00056	0.000656	CcSEcCtD
Lurasidone—Tachycardia—Doxorubicin—uterine cancer	0.00056	0.000655	CcSEcCtD
Lurasidone—Skin disorder—Doxorubicin—uterine cancer	0.000557	0.000652	CcSEcCtD
Lurasidone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000554	0.000649	CcSEcCtD
Lurasidone—Dyspnoea—Epirubicin—uterine cancer	0.000552	0.000647	CcSEcCtD
Lurasidone—Somnolence—Epirubicin—uterine cancer	0.000551	0.000645	CcSEcCtD
Lurasidone—Dyspepsia—Epirubicin—uterine cancer	0.000545	0.000639	CcSEcCtD
Lurasidone—Decreased appetite—Epirubicin—uterine cancer	0.000539	0.000631	CcSEcCtD
Lurasidone—Hypotension—Doxorubicin—uterine cancer	0.000536	0.000627	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000535	0.000626	CcSEcCtD
Lurasidone—Fatigue—Epirubicin—uterine cancer	0.000534	0.000626	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000522	0.000612	CcSEcCtD
Lurasidone—Insomnia—Doxorubicin—uterine cancer	0.000519	0.000607	CcSEcCtD
Lurasidone—Dyspnoea—Doxorubicin—uterine cancer	0.000511	0.000599	CcSEcCtD
Lurasidone—Somnolence—Doxorubicin—uterine cancer	0.00051	0.000597	CcSEcCtD
Lurasidone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000507	0.000593	CcSEcCtD
Lurasidone—Dyspepsia—Doxorubicin—uterine cancer	0.000505	0.000591	CcSEcCtD
Lurasidone—Decreased appetite—Doxorubicin—uterine cancer	0.000498	0.000584	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000495	0.00058	CcSEcCtD
Lurasidone—Fatigue—Doxorubicin—uterine cancer	0.000494	0.000579	CcSEcCtD
Lurasidone—Abdominal pain—Epirubicin—uterine cancer	0.00049	0.000574	CcSEcCtD
Lurasidone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000469	0.000549	CcSEcCtD
Lurasidone—Abdominal pain—Doxorubicin—uterine cancer	0.000453	0.000531	CcSEcCtD
Lurasidone—Asthenia—Epirubicin—uterine cancer	0.000445	0.000521	CcSEcCtD
Lurasidone—Pruritus—Epirubicin—uterine cancer	0.000438	0.000513	CcSEcCtD
Lurasidone—Diarrhoea—Epirubicin—uterine cancer	0.000424	0.000496	CcSEcCtD
Lurasidone—Asthenia—Doxorubicin—uterine cancer	0.000411	0.000482	CcSEcCtD
Lurasidone—Dizziness—Epirubicin—uterine cancer	0.00041	0.00048	CcSEcCtD
Lurasidone—Pruritus—Doxorubicin—uterine cancer	0.000406	0.000475	CcSEcCtD
Lurasidone—Vomiting—Epirubicin—uterine cancer	0.000394	0.000461	CcSEcCtD
Lurasidone—Diarrhoea—Doxorubicin—uterine cancer	0.000392	0.000459	CcSEcCtD
Lurasidone—Rash—Epirubicin—uterine cancer	0.000391	0.000457	CcSEcCtD
Lurasidone—Dermatitis—Epirubicin—uterine cancer	0.00039	0.000457	CcSEcCtD
Lurasidone—Dizziness—Doxorubicin—uterine cancer	0.000379	0.000444	CcSEcCtD
Lurasidone—Nausea—Epirubicin—uterine cancer	0.000368	0.000431	CcSEcCtD
Lurasidone—Vomiting—Doxorubicin—uterine cancer	0.000365	0.000427	CcSEcCtD
Lurasidone—Rash—Doxorubicin—uterine cancer	0.000361	0.000423	CcSEcCtD
Lurasidone—Dermatitis—Doxorubicin—uterine cancer	0.000361	0.000423	CcSEcCtD
Lurasidone—Nausea—Doxorubicin—uterine cancer	0.000341	0.000399	CcSEcCtD
